CPT1A and cardiac hypertrophy: Yang et al. examined the levels of the lncRNA MIAT in cardiac hypertrophy and found that the overexpression of MIAT and the downstream response molecule Ythdf2 exacerbates cardiac hypertrophy (38) through the PPARα/CPT-1a signaling pathway (Figure 2).